Role of PAF receptor in proinflammatory cytokine expression in the dorsal root ganglion and tactile allodynia in a rodent model of neuropathic pain

PLoS ONE

Volumn 5, Issue 5, 2010, Pages

  Hasegawa, Shigeo ^a   Kohro, Yuta ^a   Shiratori, Miho ^a   Ishii, Satoshi ^b   Shimizu, Takao ^b   Tsuda, Makoto ^a   Inoue, Kazuhide ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; [2 METHOXY 3 (N OCTADECYLCARBAMOYLOXY)PROPYL] (2 THIAZOLIOETHYL) PHOSPHATE; BAICALEIN; DOCEBENONE; ENZYME INHIBITOR; INTERLEUKIN 1BETA; KI 16425; LIPOXYGENASE INHIBITOR; MESSENGER RNA; PROSTAGLANDIN SYNTHASE INHIBITOR; THROMBOCYTE ACTIVATING FACTOR RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG ACTIVITY; GENE REPRESSION; HYPERSENSITIVITY; MACROPHAGE; MALE; MECHANICAL STIMULATION; NERVE INJURY; NEUROPATHIC PAIN; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; RAT; SPINAL GANGLION; TACTILE ALLODYNIA; UPREGULATION;

1-ACYLGLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE; ANIMALS; CYCLOOXYGENASE INHIBITORS; DISEASE MODELS, ANIMAL; GANGLIA, SPINAL; INFLAMMATION MEDIATORS; INJECTIONS; INTERLEUKIN-1BETA; LIPOXYGENASE INHIBITORS; MICE; MODELS, BIOLOGICAL; PAIN; PERIPHERAL NERVE INJURIES; PERIPHERAL NERVES; PLATELET ACTIVATING FACTOR; PLATELET MEMBRANE GLYCOPROTEINS; RATS; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, LYSOPHOSPHATIDIC ACID; TOUCH; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

MUS; RATTUS; RODENTIA;

EID: 77956288531     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0010467     Document Type: Article

References (66)

1. Woolf CJ, Mannion RJ (1999) Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 353: 1959-1964.
2. Woolf CJ, Salter MW (2000) Neuronal plasticity: increasing the gain in pain. Science 288: 1765-1769.
3. Scholz J, Woolf CJ (2002) Can we conquer pain? Nat Neurosci 5 Suppl: 1062-1067.
4. Shimizu T, Ohto T, Kita Y (2006) Cytosolic phospholipase A2: biochemical properties and physiological roles. IUBMB Life 58: 328-333.
5. Tsuda M, Hasegawa S, Inoue K (2007) P2X receptors-mediated cytosolic phospholipase A2 activation in primary afferent sensory neurons contributes to neuropathic pain. J Neurochem 103: 1408-1416.
6. Park KA, Vasko MR (2005) Lipid mediators of sensitivity in sensory neurons. Trends Pharmacol Sci 26: 571-577.
7. Minami T, Uda R, Horiguchi S, Ito S, Hyodo M, et al. (1992) Allodynia evoked by intrathecal administration of prostaglandin F2 alpha to conscious mice. Pain 50: 223-229.
8. Minami T, Uda R, Horiguchi S, Ito S, Hyodo M, et al. (1994) Allodynia evoked by intrathecal administration of prostaglandin E2 to conscious mice. Pain 57: 217-223.
9. Hwang SW, Cho H, Kwak J, Lee SY, Kang CJ, et al. (2000) Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances. Proc Natl Acad Sci U S A 97: 6155-6160.
10. Shin J, Cho H, Hwang SW, Jung J, Shin CY, et al. (2002) Bradykinin-12- lipoxygenase-VR1 signaling pathway for inflammatory hyperalgesia. Proc Natl Acad Sci U S A 99: 10150-10155.
11. Marotta DM, Costa R, Motta EM, Fernandes ES, Medeiros R, et al. (2009) Mechanisms underlying the nociceptive responses induced by platelet-activating factor (PAF) in the rat paw. Biochem Pharmacol 77: 1223-1235.
12. Inoue M, Rashid MH, Fujita R, Contos JJ, Chun J, et al. (2004) Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling. Nat Med 10: 712-718.
13. Morita K, Morioka N, Abdin J, Kitayama S, Nakata Y, et al. (2004) Development of tactile allodynia and thermal hyperalgesia by intrathecally administered platelet-activating factor in mice. Pain 111: 351-359.
14. Morita K, Kitayama T, Morioka N, Dohi T (2008) Glycinergic mediation of tactile allodynia induced by platelet-activating factor (PAF) through glutamate- NO-cyclic GMP signalling in spinal cord in mice. Pain 138: 525-536.
15. Schafers M, Svensson CI, Sommer C, Sorkin LS (2003) Tumor necrosis factoralpha induces mechanical allodynia after spinal nerve ligation by activation of p38 MAPK in primary sensory neurons. J Neurosci 23: 2517-2521.
16. Mika J, Korostynski M, Kaminska D, Wawrzczak-Bargiela A, Osikowicz M, et al. (2008) Interleukin-1alpha has antiallodynic and antihyperalgesic activities in a rat neuropathic pain model. Pain 138: 587-597.
17. Kawasaki Y, Xu ZZ, Wang X, Park JY, Zhuang ZY, et al. (2008) Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain. Nat Med 14: 331-336.
18. Schafers M, Lee DH, Brors D, Yaksh TL, Sorkin LS (2003) Increased sensitivity of injured and adjacent uninjured rat primary sensory neurons to exogenous tumor necrosis factor-alpha after spinal nerve ligation. J Neurosci 23: 3028-3038.
19. Chopra B, Giblett S, Little JG, Donaldson LF, Tate S, et al. (2000) Cyclooxygenase-1 is a marker for a subpopulation of putative nociceptive neurons in rat dorsal root ganglia. Eur J Neurosci 12: 911-920.
20. Dou W, Jiao Y, Goorha S, Raghow R, Ballou LR (2004) Nociception and the differential expression of cyclooxygenase-1 (COX-1), the COX-1 variant retaining intron-1 (COX-1v), and COX-2 in mouse dorsal root ganglia (DRG). Prostaglandins Other Lipid Mediat 74: 29-43.
21. Smith CJ, Zhang Y, Koboldt CM, Muhammad J, Zweifel BS, et al. (1998) Pharmacological analysis of cyclooxygenase-1 in inflammation. Proc Natl Acad Sci U S A 95: 13313-13318.
22. Yoshimoto T, Yokoyama C, Ochi K, Yamamoto S, Maki Y, et al. (1982) 2,3,5- Trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone (AA861), a selective inhibitor of the 5-lipoxygenase reaction and the biosynthesis of slowreacting substance of anaphylaxis. Biochim Biophys Acta 713: 470-473.
23. Cho H, Ueda M, Tamaoka M, Hamaguchi M, Aisaka K, et al. (1991) Novel caffeic acid derivatives: extremely potent inhibitors of 12-lipoxygenase. J Med Chem 34: 1503-1505.
24. Sadik CD, Sies H, Schewe T (2003) Inhibition of 15-lipoxygenases by flavonoids: structure-activity relations and mode of action. Biochem Pharmacol 65: 773-781.
25. Ririe DG, Prout HD, Barclay D, Tong C, Lin M, et al. (2006) Developmental differences in spinal cyclooxygenase 1 expression after surgical incision. Anesthesiology 104: 426-431.
26. Zhu X, Conklin D, Eisenach JC (2003) Cyclooxygenase-1 in the spinal cord plays an important role in postoperative pain. Pain 104: 15-23.
27. Trang T, McNaull B, Quirion R, Jhamandas K (2004) Involvement of spinal lipoxygenase metabolites in hyperalgesia and opioid tolerance. Eur J Pharmacol 491: 21-30.
28. Trang T, Sutak M, Quirion R, Jhamandas K (2003) Spinal administration of lipoxygenase inhibitors suppresses behavioural and neurochemical manifestations of naloxone-precipitated opioid withdrawal. Br J Pharmacol 140: 295-304.
29. Terashita Z, Tsushima S, Yoshioka Y, Nomura H, Inada Y, et al. (1983) CV- 3988 - a specific antagonist of platelet activating factor (PAF). Life Sci 32: 1975-1982.
30. Ohta H, Sato K, Murata N, Damirin A, Malchinkhuu E, et al. (2003) Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors. Mol Pharmacol 64: 994-1005.
31. Ma L, Matsumoto M, Xie W, Inoue M, Ueda H (2009) Evidence for lysophosphatidic acid 1 receptor signaling in the early phase of neuropathic pain mechanisms in experiments using Ki-16425, a lysophosphatidic acid 1 receptor antagonist. J Neurochem 109: 603-610.
32. Shindou H, Hishikawa D, Nakanishi H, Harayama T, Ishii S, et al. (2007) A single enzyme catalyzes both platelet-activating factor production and membrane biogenesis of inflammatory cells. Cloning and characterization of acetyl-CoA:LYSO-PAF acetyltransferase. J Biol Chem 282: 6532-6539.
33. Harayama T, Shindou H, Ogasawara R, Suwabe A, Shimizu T (2008) Identification of a novel noninflammatory biosynthetic pathway of plateletactivating factor. J Biol Chem 283: 11097-11106.
34. Kihara Y, Yanagida K, Masago K, Kita Y, Hishikawa D, et al. (2008) Plateletactivating factor production in the spinal cord of experimental allergic encephalomyelitis mice via the group IVA cytosolic phospholipase A2-lyso- PAFAT axis. J Immunol 181: 5008-5014.
35. Ishii S, Shimizu T (2000) Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice. Prog Lipid Res 39: 41-82.
36. Ishii S, Kuwaki T, Nagase T, Maki K, Tashiro F, et al. (1998) Impaired anaphylactic responses with intact sensitivity to endotoxin in mice lacking a platelet-activating factor receptor. J Exp Med 187: 1779-1788.
37. Tsuda M, Ishii S, Masuda T, Hasegawa S, Nakamura K, et al. (2007) Reduced pain behaviors and extracellular signal-related protein kinase activation in primary sensory neurons by peripheral tissue injury in mice lacking plateletactivating factor receptor. J Neurochem 102: 1658-1668.
38. Schafers M, Geis C, Svensson CI, Luo ZD, Sommer C (2003) Selective increase of tumour necrosis factor-alpha in injured and spared myelinated primary afferents after chronic constrictive injury of rat sciatic nerve. Eur J Neurosci 17: 791-804.
39. Kihara Y, Ishii S, Kita Y, Toda A, Shimada A, et al. (2005) Dual phase regulation of experimental allergic encephalomyelitis by platelet-activating factor. J Exp Med 202: 853-863.
40. Fernandes ES, Passos GF, Campos MM, de Souza GE, Fittipaldi JF, et al. (2005) Cytokines and neutrophils as important mediators of platelet-activating factorinduced kinin B1 receptor expression. Br J Pharmacol 146: 209-216.
41. Hefferan MP, O'Rielly DD, Loomis CW (2003) Inhibition of spinal prostaglandin synthesis early after L5/L6 nerve ligation prevents the development of prostaglandin-dependent and prostaglandin-independent allodynia in the rat. Anesthesiology 99: 1180-1188.
42. Zhu X, Eisenach JC (2003) Cyclooxygenase-1 in the spinal cord is altered after peripheral nerve injury. Anesthesiology 99: 1175-1179.
43. Zhao Z, Chen SR, Eisenach JC, Busija DW, Pan HL (2000) Spinal cyclooxygenase-2 is involved in development of allodynia after nerve injury in rats. Neuroscience 97: 743-748.
44. Kost RG, Straus SE (1996) Postherpetic neuralgia-pathogenesis, treatment, and prevention. N Engl J Med 335: 32-42.
45. Samuelsson B (1983) Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science 220: 568-575.
46. Levine JD, Lau W, Kwiat G, Goetzl EJ (1984) Leukotriene B4 produces hyperalgesia that is dependent on polymorphonuclear leukocytes. Science 225: 743-745.
47. Levine JD, Lam D, Taiwo YO, Donatoni P, Goetzl EJ (1986) Hyperalgesic properties of 15-lipoxygenase products of arachidonic acid. Proc Natl Acad Sci U S A 83: 5331-5334.
48. Doi K, Okamoto K, Negishi K, Suzuki Y, Nakao A, et al. (2006) Attenuation of folic acid-induced renal inflammatory injury in platelet-activating factor receptor-deficient mice. Am J Pathol 168: 1413-1424.
49. Scholz J, Woolf CJ (2007) The neuropathic pain triad: neurons, immune cells and glia. Nat Neurosci 10: 1361-1368.
50. Marchand F, Perretti M, McMahon SB (2005) Role of the immune system in chronic pain. Nat Rev Neurosci 6: 521-532.
51. Mantyh PW (2006) Cancer pain and its impact on diagnosis, survival and quality of life. Nat Rev Neurosci 7: 797-809.
52. Moalem G, Tracey DJ (2006) Immune and inflammatory mechanisms in neuropathic pain. Brain Res Rev 51: 240-264.
53. Schafers M, Geis C, Brors D, Yaksh TL, Sommer C (2002) Anterograde transport of tumor necrosis factor-alpha in the intact and injured rat sciatic nerve. J Neurosci 22: 536-545.
54. Li H, Xie W, Strong JA, Zhang JM (2007) Systemic antiinflammatory corticosteroid reduces mechanical pain behavior, sympathetic sprouting, and elevation of proinflammatory cytokines in a rat model of neuropathic pain. Anesthesiology 107: 469-477.
55. Uceyler N, Tscharke A, Sommer C (2007) Early cytokine expression in mouse sciatic nerve after chronic constriction nerve injury depends on calpain. Brain Behav Immun 21: 553-560.
56. Sacerdote P, Franchi S, Trovato AE, Valsecchi AE, Panerai AE, et al. (2008) Transient early expression of TNF-alpha in sciatic nerve and dorsal root ganglia in a mouse model of painful peripheral neuropathy. Neurosci Lett 436: 210-213.
57. Jin X, Gereau RWt (2006) Acute p38-mediated modulation of tetrodotoxinresistant sodium channels in mouse sensory neurons by tumor necrosis factoralpha. J Neurosci 26: 246-255.
58. Liu L, Yang TM, Liedtke W, Simon SA (2006) Chronic IL-1beta signaling potentiates voltage-dependent sodium currents in trigeminal nociceptive neurons. J Neurophysiol 95: 1478-1490.
59. Elmes SJ, Millns PJ, Smart D, Kendall DA, Chapman V (2004) Evidence for biological effects of exogenous LPA on rat primary afferent and spinal cord neurons. Brain Res 1022: 205-213.
60. Renback K, Inoue M, Ueda H (1999) Lysophosphatidic acid-induced, pertussis toxin-sensitive nociception through a substance P release from peripheral nerve endings in mice. Neurosci Lett 270: 59-61.
61. Hasegawa S, Kohro Y, Tsuda M, Inoue K (2009) Activation of cytosolic phospholipase A2 in dorsal root ganglion neurons by Ca2+/calmodulindependent protein kinase II after peripheral nerve injury. Mol Pain 5: 22.
62. Lindsberg PJ, Hallenbeck JM, Feuerstein G (1991) Platelet-activating factor in stroke and brain injury. Ann Neurol 30: 117-129.
63. Kim SH, Chung JM (1992) An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 50: 355-363.
64. Tsuda M, Shigemoto-Mogami Y, Koizumi S, Mizokoshi A, Kohsaka S, et al. (2003) P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature 424: 778-783.
65. Tsuda M, Masuda T, Kitano J, Shimoyama H, Tozaki-Saitoh H, et al. (2009) IFN-gamma receptor signaling mediates spinal microglia activation driving neuropathic pain. Proc Natl Acad Sci U S A 106: 8032-8037.
66. Obata K, Yamanaka H, Kobayashi K, Dai Y, Mizushima T, et al. (2004) Role of mitogen-activated protein kinase activation in injured and intact primary afferent neurons for mechanical and heat hypersensitivity after spinal nerve ligation. J Neurosci 24: 10211-10222.